ATE360459T1 - Auf xanthin basierende, schlankmachende zusammensetzung enthaltend ein dimethiconcopolyol und ein polyurethanpulver - Google Patents

Auf xanthin basierende, schlankmachende zusammensetzung enthaltend ein dimethiconcopolyol und ein polyurethanpulver

Info

Publication number
ATE360459T1
ATE360459T1 AT05292099T AT05292099T ATE360459T1 AT E360459 T1 ATE360459 T1 AT E360459T1 AT 05292099 T AT05292099 T AT 05292099T AT 05292099 T AT05292099 T AT 05292099T AT E360459 T1 ATE360459 T1 AT E360459T1
Authority
AT
Austria
Prior art keywords
xanthine
dimethicone copolyol
polyurethane powder
composition containing
slimming composition
Prior art date
Application number
AT05292099T
Other languages
English (en)
Inventor
Moreno Angeles Fonolla
Bertrand Piot
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Application granted granted Critical
Publication of ATE360459T1 publication Critical patent/ATE360459T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/87Polyurethanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89Polysiloxanes
    • A61K8/891Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A61K8/894Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone modified by a polyoxyalkylene group, e.g. cetyl dimethicone copolyol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9771Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/06Preparations for care of the skin for countering cellulitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AT05292099T 2004-12-17 2005-10-10 Auf xanthin basierende, schlankmachende zusammensetzung enthaltend ein dimethiconcopolyol und ein polyurethanpulver ATE360459T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0453051A FR2879448B1 (fr) 2004-12-17 2004-12-17 Composition amincissante comprenant une base xanthique, un dimethicone copolyol et une poudre de polyurethane

Publications (1)

Publication Number Publication Date
ATE360459T1 true ATE360459T1 (de) 2007-05-15

Family

ID=34951641

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05292099T ATE360459T1 (de) 2004-12-17 2005-10-10 Auf xanthin basierende, schlankmachende zusammensetzung enthaltend ein dimethiconcopolyol und ein polyurethanpulver

Country Status (5)

Country Link
EP (1) EP1676606B1 (de)
AT (1) ATE360459T1 (de)
DE (1) DE602005000986T2 (de)
ES (1) ES2286777T3 (de)
FR (1) FR2879448B1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0719545D0 (en) 2007-10-08 2007-11-14 Barry Callebaut Ag Novel use of cocoa extract
GB0719544D0 (en) 2007-10-08 2007-11-14 Barry Callebaut Ag Cocoa extract and use thereof
GB0719542D0 (en) 2007-10-08 2007-11-14 Barry Callebaut Ag Use of cocoa extract
US20090263518A1 (en) 2008-04-17 2009-10-22 Barry Callebaut Ag Composition and Uses Thereof
JP2012504600A (ja) * 2008-10-03 2012-02-23 シグマ・アリメントス・ソシエダ・アノニマ・デ・カピタル・バリアブレ 総コレステロールおよびldlコレステロールの制御ならびに/または体重減少ならびに/または熱産生を促進するための組成物
FR2950528B1 (fr) * 2009-09-29 2011-10-28 Oreal Composition amincissante

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4268499A (en) 1979-06-07 1981-05-19 Dow Corning Corporation Antiperspirant emulsion compositions
FR2669537B1 (fr) * 1990-11-28 1993-02-19 Oreal Composition amincissante a base d'alpha-2-bloqueurs.
US20030180242A1 (en) * 2001-11-01 2003-09-25 The Procter & Gamble Company Personal care compositions containing a water-disintegratable polymeric foam
FR2845912B1 (fr) * 2002-10-18 2006-06-30 Inst Jeanne Piaubert Composition cosmetique binaire pour le developpement du buste feminin et l'amelioration de la silhouette
US20040223935A1 (en) * 2003-04-09 2004-11-11 L'oreal Cosmetic composition containing a fatty acid glyceride, an alcohol and a silicone emulsifier

Also Published As

Publication number Publication date
DE602005000986D1 (de) 2007-06-06
FR2879448B1 (fr) 2007-01-26
FR2879448A1 (fr) 2006-06-23
EP1676606B1 (de) 2007-04-25
DE602005000986T2 (de) 2008-01-17
ES2286777T3 (es) 2007-12-01
EP1676606A1 (de) 2006-07-05

Similar Documents

Publication Publication Date Title
ATE376065T1 (de) Enzymatische herstellung urethangruppenhaltiger (meth)acrylsäureeester
WO2008070797A3 (en) System and method for transapical delivery of an annulus anchored self-expanding valve
AU2003201274A8 (en) Compositions comprising inhibitors of dpp-iv and nep enzymes for the treatment of diabetes
CY1109351T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν διαμινοοξειδαση
ATE360459T1 (de) Auf xanthin basierende, schlankmachende zusammensetzung enthaltend ein dimethiconcopolyol und ein polyurethanpulver
EP2641608A3 (de) Verwendung von Sojapeptid (Lunasin) zur Senkung des Gesamt- und des LDL-Cholesterinspiegels
CN109464337A (zh) 紧致祛皱精华
ATE375810T1 (de) Cyanoamid-verbindungen als nützliche malonyl-coa decarboxylase-hemmer
WO2007062413A3 (en) Use of parp-1 inhibitors
Joles et al. Inducible nitric oxide synthase in renal transplantation
WO2005120549A3 (en) Local delivery of growth factors for stem cell transplantation
HK1042852A1 (zh) 增强胰岛素反应的方法
WO2003090688A3 (en) Enhancement of human epidermal melanogenesis
FR2872431B1 (fr) Utilisation de fibroplastes gingivaux en therapie cellulaire vasculaire
PT1007034E (pt) Combinacoes que contem bergamotina para aumentar a biodisponibilidade oral de agentes farmaceuticos
WO2005058314A3 (en) Methods for reducing the effects of stress on skin condition
WO2009035253A3 (en) Novel use of scoparone
DE602007005664D1 (de) Verwendung eines quinoa-extrakts als kosmetisches und pharmazeutisches schlankheitsmittel und/oder als mittel zur verhinderung der formierung neuer fette im menschlichen körper
WO2005037258A3 (en) Cyanoguanidine-based azole compounds useful as malonyl-coa decarboxylase inhibitors
DK1494746T3 (da) Insulin til anvendelse i en dosering
Sullivan Lacking in self-esteem? Good for you!
DE602005001849D1 (de) Orale diätzusammensetzung, enthaltend konjugierte linolsäure und coffein
PL1474999T3 (pl) Preparat uzupełniający odżywianie zawierający kwas alfa-liponowy i antocyjanozydy
CA2598786A1 (en) Composition and method for increasing the anabolic state of muscle cells
Mascaro et al. Spiritual Meaning Scale

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties